Cargando…
Integrating Hepatitis C Care for Opioid Substitution Treatment Patients Attending General Practice: Feasibility, Clinical, and Cost-Effectiveness Analysis
BACKGROUND: Hepatitis C virus (HCV) infection is common among people who inject drugs, yet well-described barriers mean that only a minority have accessed HCV treatment. Recent developments in HCV diagnosis and treatment facilitate innovative approaches to HCV care that improve access to, and uptake...
Autores principales: | McCombe, Geoff, Swan, Davina, Lambert, John S, O’Connor, Eileen, Ward, Zoe, Vickerman, Peter, Avramovic, Gordana, Crowley, Des, Tinago, Willard, Mafirakureva, Nyashadzaishe, Cullen, Walter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449831/ https://www.ncbi.nlm.nih.gov/pubmed/35998029 http://dx.doi.org/10.2196/35300 |
Ejemplares similares
-
Hepatitis C Prevalence and Management Among Patients Receiving Opioid Substitution Treatment in General Practice in Ireland: Baseline Data from a Feasibility Study
por: Murtagh, Ross, et al.
Publicado: (2018) -
Integrated Hepatitis C Care for People Who Inject Drugs (Heplink): Protocol for a Feasibility Study in Primary Care
por: McCombe, Geoff, et al.
Publicado: (2018) -
Integrating hepatitis C care for at-risk groups (HepLink): baseline data from a multicentre feasibility study in primary and community care
por: Nic An Riogh, Eithne, et al.
Publicado: (2019) -
General practice attendances among patients attending a post-COVID-19 clinic: a pilot study
por: Broughan, John, et al.
Publicado: (2021) -
Integrating primary and secondary care to optimize hepatitis C treatment: development and evaluation of a multidisciplinary educational Masterclass series
por: McCombe, Geoff, et al.
Publicado: (2019)